A smart cancer drug ( RK-251 ) activating primarily in cancer cells, could replace chemotherapy
A new "smart" cancer drug designed to switch on and work only inside cancer cells can replace traditional chemotherapy, which in many cases also harms healthy cells. Cancer treatment often damages healthy cells along with cancer cells, causing significant associated adverse effects and side effects. This has created a need for targeted therapies that remain inactive in normal tissues while it travels through the body and become activated specifically at tumor sites. Scientists have taken an important step toward making this idea a reality. Collaborative research led by Dr. Asis Bala from the Institute of Advanced Study in Science and Technology (IASST), an Autonomous Institute under the Department of Science & Technology (Govt. of India), and Dr. K.P. Bhabak from the Indian Institute of Technology-Guwahati has developed a new "smart" cancer drug called RK-251. RK-251 is designed to activate primarily in cancer cells and does not harm healthy cells. Fig : Schemat...